Bcl2-associated athanogene 3 (BAG3) is elevated in several types of cancers. However, the role of BAG3 in progression of gastric cancer is unknown. Therefore, the present study aims to find out the role of BAG3 in hepatocyte growth factor (HGF)–mediated tumor progression and the molecular mechanisms by which HGF regulates BAG3 expression.
Methods:
BAG3 mRNA and protein were measured using reverse transcription polymerase chain reaction and Western blot in the 2 human gastric cancer cell lines, NUGC3 and MKN28, treated with or without HGF. The effects of BAG3 knockdown on cell proliferation, cell invasion, and apoptosis were analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, the in vitro 2-chamber invasion assay, and flow cytometry in BAG3 short hairpin RNA (shRNA)–transfected cells and control cells. The signaling pathways involved in BAG3 that are regulated by HGF were analyzed. The chromatin immunoprecipitation assay was used to determine binding of Egr1 to the BAG3 promoter.
Results:
BAG3 mRNA and protein levels were increased following treatment with HGF. HGF-mediated BAG3 upregulation increased cell proliferation and cell invasion; however, it decreased apoptosis. HGF-mediated BAG3 upregulation is regulated by an ERK and Egr1-dependent pathway. BAG3 may have an important role in HGF-mediated cell proliferation and metastasis in gastric cancer through an ERK and Egr1-dependent pathway.
Conclusion:
This pathway may provide novel therapeutic targets and provide information for further identification of other targets of therapeutic significance in gastric cancer.
SiegelRLMillerKDJemalA.Cancer statistics, 2016. CA Cancer J Clin2016; 66: 7–30.
2.
BryanBADennstedtEMitchellDCet al. RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis. FASEB J2010; 24: 3186–3195.
3.
CaoYLindenPFarneboJet al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA1998; 95: 14389–14394.
4.
ChellaiahMASogaNSwansonSet al. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem2000; 275: 11993–12002.
5.
LeeKHChoiEYKohSAet al. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB. Exp Mol Med2011; 43: 501–509.
6.
LeeKHChoiEYKimMKet al. Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer. Mol Cell Biochem2010; 343: 163–171.
7.
FuchsMPoirierDJSeguinSJet al. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem J2009; 425: 245–255.
ShiPFangCPangX.Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma. Oncol Rep2015; 34: 1319–1326.
10.
BrunoAPFestaMDal PiazFet al. Identification of a synaptosome-associated form of BAG3 protein. Cell Cycle2008; 7: 3104–3105.
11.
DoongHVrailasAKohnEC.What’s in the ‘BAG’? A functional domain analysis of the BAG-family proteins. Cancer Lett2002; 188: 25–32.
12.
PagliucaMGLeroseRCiglianoSLeoneA.Regulation by heavy metals and temperature of the human BAG-3 gene, a modulator of Hsp70 activity. FEBS Lett2003; 541: 11–15.
13.
RosatiAAmmiranteMGentilellaAet al. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol2007; 39: 1337–1342.
14.
AmmiranteMRosatiAArraCet al. IKKγ protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA2010; 107: 7497–7502.
15.
IwasakiMHommaSHishiyaADolezalSJReedJCTakayamaS.BAG3 regulates motility and adhesion of epithelial cancer cells. Cancer Res2007; 67: 10252–10259.
16.
JacobsATMarnettLJ.HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem2009; 284: 9176–9183.
17.
LiaoQOzawaFFriessHet al. The anti-apoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett2001; 503: 151–157.
18.
StaibanoSMascoloMDi BenedettoMet al. BAG3 protein delocalisation in prostate carcinoma. Tumour Biol2010; 31: 461–469.
19.
RosatiAGrazianoVDe LaurenziVPascaleMTurcoMC.BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis2011; 2: e141.
20.
KassisJNGuancialEADoongHViradorVKohnEC.CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res2006; 312: 2962–2971.
21.
KassisJNViradorVMGuancialEAet al. Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J Pathol2009; 218: 495–504.
22.
VoellmyRBoellmannF.Chaperone regulation of the heat shock protein response. Adv Exp Med Biol2007; 594: 89–99.
23.
GentilellaAPassiatoreGDeshmaneSTurcoMCKhaliliK.Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene2008; 27: 5011–5018.
24.
Ben AichaSLessardJPelletierMFournierACalvoELabrieC. Transcriptional profiling of genes that are regulated by the endoplasmic reticulum-bound transcription factor AIbZIP/CREB3L4 in prostate cells. Physiol Genomics2007; 31: 295–305.
25.
CesaroEMontanoGRosatiAet al. WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia2010; 24: 1204–1206.
26.
ChavrierPZerialMLemairePAlmendralJBravoRCharnayP.A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J1988; 7: 29–35.
27.
SukhatmeVPCaoXMChangLCet al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell1988; 53: 37–43.
28.
BaekSJKimJSMooreSMLeeSHMartinezJElingTE.Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol2005; 67: 356–364.
29.
FahmyRGDassCRSunLQChestermanCNKhachigianLM.Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med2003; 9: 1026–1032.
30.
LeeKHKimJR.Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells. Clin Exp Metastasis2009; 26: 685–692.
31.
DuZXMengXZhangHYGuanYWangHQ.Caspase-dependent cleavage of BAG3 in proteasome inhibitors-induced apoptosis in thyroid cancer cells. Biochem Biophys Res Commun2008; 369: 894–898.
Stetler-StevensonWGAznavoorianSLiottaLA.Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol1993; 9: 541–573.
34.
SuzukiMIwasakiMSugioAet al. BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett2011; 303: 65–71.
35.
YangSHKimJSOhTJet al. Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol2003; 22: 741–750.
36.
BussolinoFDi RenzoMFZicheMet al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol1992; 119: 629–641.
37.
LeeKHKimJR.Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor. Exp Mol Med2009; 41: 180–188.
38.
ShiHXuHLiZet al. BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer. Tumour Biol2016; 37: 5591–5597.
39.
ChiappettaGAmmiranteMBasileAet al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab2007; 92: 1159–1163.
40.
WangHQMengXGaoYYet al. Characterization of BAG3 cleavage during apoptosis of pancreatic cancer cells. J Cell Physiol2010; 224: 94–100.
41.
LudersJDemandJHohfeldJ.The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem2000; 275: 4613–4617.
42.
FestaMDel ValleLKhaliliKet al. BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol2011; 178: 2504–2512.
43.
AshkenaziADixitVM.Death receptors: signaling and modulation. Science1998; 281: 1305–1308.
44.
AntokuKMaserRSScullyWJJr.DelachSMJohnsonDE.Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein. Biochem Biophys Res Commun2001; 286: 1003–1010.
45.
LeeJHTakahashiTYasuharaNInazawaJKamadaSTsujimotoY.Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene1999; 18: 6183–6190.
